(Q45879541)

17 December 2017

title

Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation (English)

1 reference

17 December 2017

author name string

Schauber-Plewa C

1

1 reference

17 December 2017

Simmons A

2

1 reference

17 December 2017

Tuerk MJ

3

1 reference

17 December 2017

Pacheco CD

4

1 reference

17 December 2017

Veres G

5

1 reference

17 December 2017

publication date

1 February 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

238-245

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302399

exact match

0 references

cites work

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Recombinant baculoviruses as mammalian cell gene-delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Glycoproteins from insect cells: sialylated or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Innate immunity and its role against infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Complement-protected amphotropic retroviruses from murine packaging cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

7 January 2021

Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

7 January 2021

Control of early viral and bacterial distribution and disease by natural antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302399

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302399

1 reference

17 December 2017

Dimensions Publication ID

1053622679

0 references

1 reference

17 December 2017